Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1

Oliver T. Keppler, Frank J. Welte, Tuan A. Ngo, Peggy S. Chin, Kathryn S. Patton, Chia Lin Tsou, Nancy W. Abbey, Mark E Sharkey, Robert M. Grant, Yun You, John D. Scarborough, Wilfried Ellmeier, Dan R. Littman, Mario Stevenson, Israel F. Charo, Brian G. Herndier, Roberto F. Speck, Mark A. Goldsmith

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

The development of a permissive small animal model for the study of human immunodeficiency virus type (HIV)-1 pathogenesis and the testing of antiviral strategies has been hampered by the inability of HIV-1 to infect primary rodent cells productively. In this study, we explored transgenic rats expressing the HIV-1 receptor complex as a susceptible host. Rats transgenic for human CD4 (hCD4) and the human chemokine receptor CCR5 (hCCR5) were generated that express the transgenes in CD4+ T lymphocytes, macrophages, and microglia. In ex vivo cultures, CD4+ T lymphocytes, macrophages, and microglia from hCD4/hCCR5 transgenic rats were highly susceptible to infection by HIV-1 R5 viruses leading to expression of abundant levels of early HIV-1 gene products comparable to those found in human reference cultures. Primary rat macrophages and microglia, but not lymphocytes, from double-transgenic rats could be productively infected by various recombinant and primary R5 strains of HIV-1. Moreover, after systemic challenge with HIV-1, lymphatic organs from hCD4/hCCR5 transgenic rats contained episomal 2-long terminal repeat (LTR) circles, integrated provirus, and early viral gene products, demonstrating susceptibility to HIV-1 in vivo. Transgenic rats also displayed a low-level plasma viremia early in infection. Thus, transgenic rats expressing the appropriate human receptor complex are promising candidates for a small animal model of HIV-1 infection.

Original languageEnglish
Pages (from-to)719-736
Number of pages18
JournalJournal of Experimental Medicine
Volume195
Issue number6
DOIs
StatePublished - Mar 18 2002
Externally publishedYes

Fingerprint

Transgenic Rats
HIV-1
Infection
Chemokine Receptors
Microglia
Macrophages
Animal Models
Human Immunodeficiency Virus Proteins
Virus Receptors
T-Lymphocytes
Proviruses
Terminal Repeat Sequences
Viremia
Viral Proteins
Virus Diseases
Transgenes
Antiviral Agents
Rodentia
Lymphocytes
Viruses

Keywords

  • CCR5
  • CD4
  • HIV-1
  • Macrophages
  • Transgenic rats

ASJC Scopus subject areas

  • Immunology

Cite this

Keppler, O. T., Welte, F. J., Ngo, T. A., Chin, P. S., Patton, K. S., Tsou, C. L., ... Goldsmith, M. A. (2002). Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. Journal of Experimental Medicine, 195(6), 719-736. https://doi.org/10.1084/jem.20011549

Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. / Keppler, Oliver T.; Welte, Frank J.; Ngo, Tuan A.; Chin, Peggy S.; Patton, Kathryn S.; Tsou, Chia Lin; Abbey, Nancy W.; Sharkey, Mark E; Grant, Robert M.; You, Yun; Scarborough, John D.; Ellmeier, Wilfried; Littman, Dan R.; Stevenson, Mario; Charo, Israel F.; Herndier, Brian G.; Speck, Roberto F.; Goldsmith, Mark A.

In: Journal of Experimental Medicine, Vol. 195, No. 6, 18.03.2002, p. 719-736.

Research output: Contribution to journalArticle

Keppler, OT, Welte, FJ, Ngo, TA, Chin, PS, Patton, KS, Tsou, CL, Abbey, NW, Sharkey, ME, Grant, RM, You, Y, Scarborough, JD, Ellmeier, W, Littman, DR, Stevenson, M, Charo, IF, Herndier, BG, Speck, RF & Goldsmith, MA 2002, 'Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1', Journal of Experimental Medicine, vol. 195, no. 6, pp. 719-736. https://doi.org/10.1084/jem.20011549
Keppler, Oliver T. ; Welte, Frank J. ; Ngo, Tuan A. ; Chin, Peggy S. ; Patton, Kathryn S. ; Tsou, Chia Lin ; Abbey, Nancy W. ; Sharkey, Mark E ; Grant, Robert M. ; You, Yun ; Scarborough, John D. ; Ellmeier, Wilfried ; Littman, Dan R. ; Stevenson, Mario ; Charo, Israel F. ; Herndier, Brian G. ; Speck, Roberto F. ; Goldsmith, Mark A. / Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. In: Journal of Experimental Medicine. 2002 ; Vol. 195, No. 6. pp. 719-736.
@article{8751ea7e213c446a8a2bfc81615cc9c0,
title = "Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1",
abstract = "The development of a permissive small animal model for the study of human immunodeficiency virus type (HIV)-1 pathogenesis and the testing of antiviral strategies has been hampered by the inability of HIV-1 to infect primary rodent cells productively. In this study, we explored transgenic rats expressing the HIV-1 receptor complex as a susceptible host. Rats transgenic for human CD4 (hCD4) and the human chemokine receptor CCR5 (hCCR5) were generated that express the transgenes in CD4+ T lymphocytes, macrophages, and microglia. In ex vivo cultures, CD4+ T lymphocytes, macrophages, and microglia from hCD4/hCCR5 transgenic rats were highly susceptible to infection by HIV-1 R5 viruses leading to expression of abundant levels of early HIV-1 gene products comparable to those found in human reference cultures. Primary rat macrophages and microglia, but not lymphocytes, from double-transgenic rats could be productively infected by various recombinant and primary R5 strains of HIV-1. Moreover, after systemic challenge with HIV-1, lymphatic organs from hCD4/hCCR5 transgenic rats contained episomal 2-long terminal repeat (LTR) circles, integrated provirus, and early viral gene products, demonstrating susceptibility to HIV-1 in vivo. Transgenic rats also displayed a low-level plasma viremia early in infection. Thus, transgenic rats expressing the appropriate human receptor complex are promising candidates for a small animal model of HIV-1 infection.",
keywords = "CCR5, CD4, HIV-1, Macrophages, Transgenic rats",
author = "Keppler, {Oliver T.} and Welte, {Frank J.} and Ngo, {Tuan A.} and Chin, {Peggy S.} and Patton, {Kathryn S.} and Tsou, {Chia Lin} and Abbey, {Nancy W.} and Sharkey, {Mark E} and Grant, {Robert M.} and Yun You and Scarborough, {John D.} and Wilfried Ellmeier and Littman, {Dan R.} and Mario Stevenson and Charo, {Israel F.} and Herndier, {Brian G.} and Speck, {Roberto F.} and Goldsmith, {Mark A.}",
year = "2002",
month = "3",
day = "18",
doi = "10.1084/jem.20011549",
language = "English",
volume = "195",
pages = "719--736",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "6",

}

TY - JOUR

T1 - Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1

AU - Keppler, Oliver T.

AU - Welte, Frank J.

AU - Ngo, Tuan A.

AU - Chin, Peggy S.

AU - Patton, Kathryn S.

AU - Tsou, Chia Lin

AU - Abbey, Nancy W.

AU - Sharkey, Mark E

AU - Grant, Robert M.

AU - You, Yun

AU - Scarborough, John D.

AU - Ellmeier, Wilfried

AU - Littman, Dan R.

AU - Stevenson, Mario

AU - Charo, Israel F.

AU - Herndier, Brian G.

AU - Speck, Roberto F.

AU - Goldsmith, Mark A.

PY - 2002/3/18

Y1 - 2002/3/18

N2 - The development of a permissive small animal model for the study of human immunodeficiency virus type (HIV)-1 pathogenesis and the testing of antiviral strategies has been hampered by the inability of HIV-1 to infect primary rodent cells productively. In this study, we explored transgenic rats expressing the HIV-1 receptor complex as a susceptible host. Rats transgenic for human CD4 (hCD4) and the human chemokine receptor CCR5 (hCCR5) were generated that express the transgenes in CD4+ T lymphocytes, macrophages, and microglia. In ex vivo cultures, CD4+ T lymphocytes, macrophages, and microglia from hCD4/hCCR5 transgenic rats were highly susceptible to infection by HIV-1 R5 viruses leading to expression of abundant levels of early HIV-1 gene products comparable to those found in human reference cultures. Primary rat macrophages and microglia, but not lymphocytes, from double-transgenic rats could be productively infected by various recombinant and primary R5 strains of HIV-1. Moreover, after systemic challenge with HIV-1, lymphatic organs from hCD4/hCCR5 transgenic rats contained episomal 2-long terminal repeat (LTR) circles, integrated provirus, and early viral gene products, demonstrating susceptibility to HIV-1 in vivo. Transgenic rats also displayed a low-level plasma viremia early in infection. Thus, transgenic rats expressing the appropriate human receptor complex are promising candidates for a small animal model of HIV-1 infection.

AB - The development of a permissive small animal model for the study of human immunodeficiency virus type (HIV)-1 pathogenesis and the testing of antiviral strategies has been hampered by the inability of HIV-1 to infect primary rodent cells productively. In this study, we explored transgenic rats expressing the HIV-1 receptor complex as a susceptible host. Rats transgenic for human CD4 (hCD4) and the human chemokine receptor CCR5 (hCCR5) were generated that express the transgenes in CD4+ T lymphocytes, macrophages, and microglia. In ex vivo cultures, CD4+ T lymphocytes, macrophages, and microglia from hCD4/hCCR5 transgenic rats were highly susceptible to infection by HIV-1 R5 viruses leading to expression of abundant levels of early HIV-1 gene products comparable to those found in human reference cultures. Primary rat macrophages and microglia, but not lymphocytes, from double-transgenic rats could be productively infected by various recombinant and primary R5 strains of HIV-1. Moreover, after systemic challenge with HIV-1, lymphatic organs from hCD4/hCCR5 transgenic rats contained episomal 2-long terminal repeat (LTR) circles, integrated provirus, and early viral gene products, demonstrating susceptibility to HIV-1 in vivo. Transgenic rats also displayed a low-level plasma viremia early in infection. Thus, transgenic rats expressing the appropriate human receptor complex are promising candidates for a small animal model of HIV-1 infection.

KW - CCR5

KW - CD4

KW - HIV-1

KW - Macrophages

KW - Transgenic rats

UR - http://www.scopus.com/inward/record.url?scp=0037128659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037128659&partnerID=8YFLogxK

U2 - 10.1084/jem.20011549

DO - 10.1084/jem.20011549

M3 - Article

C2 - 11901198

AN - SCOPUS:0037128659

VL - 195

SP - 719

EP - 736

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 6

ER -